In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Brought to you by

Deerfield wins sweetened bid to acquire NitroMed

Executive Summary

After upping the ante twice, investment firm Deerfield Management has won its latest bid to acquire nitric oxide therapeutics biotech NitroMed for $0.80 in cash for each outstanding share--60% higher than its original offer--or about $36.8mm (over twice NitroMed's 2007 sales).

Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Acquisition
    • Buy-out
    • Full Acquisition
    • Includes Contract
    • Payment Includes Cash for Equity

Related Companies

UsernamePublicRestriction

Register